With the new shift at the top in the psych business unit, what’s next for reps? Nothing as of today but wish they would be more open. Not hitting goals with Rex, the launch didn’t go as planned last year, Trintellix isn’t much longer with patent and now waiting for another indication hopefully for Rex. Just feels like more to come down in near future? And they are putting more into migraine with new openings.